CHICKEN SOUP FOR THE SOUL EN (CSSE) Stock Fundamental Analysis

NASDAQ:CSSE • US16842Q1004

0.1055 USD
-0.01 (-10.21%)
At close: Jul 2, 2024
0.054 USD
-0.05 (-48.82%)
After Hours: 7/2/2024, 8:13:23 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

CSSE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 80 industry peers in the Entertainment industry. CSSE may be in some trouble as it scores bad on both profitability and health. CSSE is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • CSSE had negative earnings in the past year.
  • In the past year CSSE has reported a negative cash flow from operations.
  • In the past 5 years CSSE always reported negative net income.
  • In the past 5 years CSSE always reported negative operating cash flow.
CSSE Yearly Net Income VS EBIT VS OCF VS FCFCSSE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 -200M -400M -600M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -152.35%, CSSE is doing worse than 92.11% of the companies in the same industry.
Industry RankSector Rank
ROA -152.35%
ROE N/A
ROIC N/A
ROA(3y)-62.52%
ROA(5y)-47.4%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CSSE Yearly ROA, ROE, ROICCSSE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 100 -100 -150

1.3 Margins

  • CSSE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CSSE Yearly Profit, Operating, Gross MarginsCSSE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 200 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • CSSE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CSSE has more shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, CSSE has a worse debt to assets ratio.
CSSE Yearly Shares OutstandingCSSE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
CSSE Yearly Total Debt VS Total AssetsCSSE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

  • CSSE has an Altman-Z score of -4.31. This is a bad value and indicates that CSSE is not financially healthy and even has some risk of bankruptcy.
  • CSSE has a worse Altman-Z score (-4.31) than 81.58% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -4.31
ROIC/WACCN/A
WACC1.09%
CSSE Yearly LT Debt VS Equity VS FCFCSSE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M -400M

2.3 Liquidity

  • CSSE has a Current Ratio of 0.53. This is a bad value and indicates that CSSE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.53, CSSE is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
  • CSSE has a Quick Ratio of 0.53. This is a bad value and indicates that CSSE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CSSE's Quick ratio of 0.53 is on the low side compared to the rest of the industry. CSSE is outperformed by 72.37% of its industry peers.
Industry RankSector Rank
Current Ratio 0.53
Quick Ratio 0.53
CSSE Yearly Current Assets VS Current LiabilitesCSSE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • CSSE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -151.68%.
  • The Revenue for CSSE has decreased by -36.32% in the past year. This is quite bad
  • Measured over the past years, CSSE shows a very strong growth in Revenue. The Revenue has been growing by 61.38% on average per year.
EPS 1Y (TTM)-151.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.82%
Revenue 1Y (TTM)-36.32%
Revenue growth 3Y64.28%
Revenue growth 5Y61.38%
Sales Q2Q%-75%

3.2 Future

  • The Earnings Per Share is expected to grow by 23.89% on average over the next years. This is a very strong growth
  • CSSE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.04% yearly.
EPS Next Y42.18%
EPS Next 2Y62.8%
EPS Next 3Y39.86%
EPS Next 5Y23.89%
Revenue Next Year21.93%
Revenue Next 2Y18.06%
Revenue Next 3Y13.53%
Revenue Next 5Y10.04%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CSSE Yearly Revenue VS EstimatesCSSE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
CSSE Yearly EPS VS EstimatesCSSE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 -4 6 -6

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CSSE. In the last year negative earnings were reported.
  • With a Price/Forward Earnings ratio of 0.03, the valuation of CSSE can be described as very cheap.
  • 100.00% of the companies in the same industry are more expensive than CSSE, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of CSSE to the average of the S&P500 Index (28.16), we can say CSSE is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 0.03
CSSE Price Earnings VS Forward Price EarningsCSSE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CSSE Per share dataCSSE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20

4.3 Compensation for Growth

  • CSSE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as CSSE's earnings are expected to grow with 39.86% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y62.8%
EPS Next 3Y39.86%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for CSSE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

CHICKEN SOUP FOR THE SOUL EN

NASDAQ:CSSE (7/2/2024, 8:13:23 PM)

After market: 0.054 -0.05 (-48.82%)

0.1055

-0.01 (-10.21%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)05-13
Earnings (Next)08-12
Inst Owners0.05%
Inst Owner Change0%
Ins Owners3.12%
Ins Owner Change0%
Market Cap3.42M
Revenue(TTM)212.19M
Net Income(TTM)-630.84M
Analysts43.33
Price Target2.81 (2563.51%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.51
Dividend Growth(5Y)-0.36%
DP-1.69%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-72.95%
Min Revenue beat(2)-76.17%
Max Revenue beat(2)-69.74%
Revenue beat(4)0
Avg Revenue beat(4)-54.39%
Min Revenue beat(4)-76.17%
Max Revenue beat(4)-34.76%
Revenue beat(8)2
Avg Revenue beat(8)-23.46%
Revenue beat(12)2
Avg Revenue beat(12)-17.11%
Revenue beat(16)5
Avg Revenue beat(16)-11.51%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.03
P/S 0.02
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-20.06
EYN/A
EPS(NY)3.96
Fwd EY3751.28%
FCF(TTM)-0.45
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS6.54
BVpS-17.12
TBVpS-24.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -152.35%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-62.52%
ROA(5y)-47.4%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6.79%
Cap/Sales 3.26%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.53
Quick Ratio 0.53
Altman-Z -4.31
F-Score2
WACC1.09%
ROIC/WACCN/A
Cap/Depr(3y)4.58%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.01%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-151.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.82%
EPS Next Y42.18%
EPS Next 2Y62.8%
EPS Next 3Y39.86%
EPS Next 5Y23.89%
Revenue 1Y (TTM)-36.32%
Revenue growth 3Y64.28%
Revenue growth 5Y61.38%
Sales Q2Q%-75%
Revenue Next Year21.93%
Revenue Next 2Y18.06%
Revenue Next 3Y13.53%
Revenue Next 5Y10.04%
EBIT growth 1Y-31.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year224.06%
EBIT Next 3Y56.56%
EBIT Next 5Y32.71%
FCF growth 1Y60.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y77.99%
OCF growth 3YN/A
OCF growth 5YN/A

CHICKEN SOUP FOR THE SOUL EN / CSSE FAQ

Can you provide the ChartMill fundamental rating for CHICKEN SOUP FOR THE SOUL EN?

ChartMill assigns a fundamental rating of 2 / 10 to CSSE.


What is the valuation status for CSSE stock?

ChartMill assigns a valuation rating of 4 / 10 to CHICKEN SOUP FOR THE SOUL EN (CSSE). This can be considered as Fairly Valued.


How profitable is CHICKEN SOUP FOR THE SOUL EN (CSSE) stock?

CHICKEN SOUP FOR THE SOUL EN (CSSE) has a profitability rating of 0 / 10.


What is the earnings growth outlook for CHICKEN SOUP FOR THE SOUL EN?

The Earnings per Share (EPS) of CHICKEN SOUP FOR THE SOUL EN (CSSE) is expected to grow by 42.18% in the next year.